Menter, Alan M, Zoe Draelos, Jayme Heim, Ranga Gogineni, and Christopher EM Griffiths. “Efficacy and Safety by Body Weight Decile in Patients Treated With Tildrakizumab 100 Mg for 28 Weeks: Pooled Data Analysis of ReSURFACE 1 and ReSURFACE 2”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s136. Accessed July 4, 2024. https://jofskin.org/33014/index.php/skin/article/view/2007.